NeuroSigma Launches ADHD Trial for Children with FAS Using Monarch eTNS
Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external...